William Muinos, MD
Pediatric Gastroenterology · Miami, FLNPI 1164457834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 144 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$596
- Sanofi$352
- Nestle Healthcare Nutrition Inc.$331
- QOL Medical, LLC$282
- Janssen Scientific Affairs, LLC$261
- Mirum Pharmaceuticals, Inc.$212
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,603100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $596 |
| Sanofi | 12 | $352 |
| Nestle Healthcare Nutrition Inc. | 19 | $331 |
| QOL Medical, LLC | 20 | $282 |
| Janssen Scientific Affairs, LLC | 4 | $261 |
| Mirum Pharmaceuticals, Inc. | 5 | $212 |
| Medtronic | 1 | $150 |
| Albireo Pharma, Inc. | 2 | $145 |
| Rhythm Pharmaceuticals, Inc. | 2 | $137 |
| Regeneron | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| Aimmune Therapeutics, Inc. | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Travere Therapeutics, Inc. | 4 | $98 |
| Ipsen Biopharmaceuticals, Inc | 4 | $86 |
| Alfasigma USA, Inc. | 4 | $71 |
| Johnson & Johnson | 5 | $67 |
| Pfizer | 3 | $54 |
| Orphalan Inc | 2 | $47 |
| Amgen | 1 | $38 |
| Phadia US Inc. | 2 | $35 |
| Organon | 2 | $30 |
| Mauna Kea Technologies, Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Vivus LLC | 1 | $19 |
| Aegerion Pharmaceuticals, Inc. | 1 | $18 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Laborie Medical Technologies Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,603 in reported general payments places this provider in the 70th percentile of 128 pediatric gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DificidFidaxomicin | 16 | $96,409 |
| Sucralfate | 39 | $5,066 |
| Famotidine | 20 | $2,863 |
| Cholestyramine LightCholestyramine | 14 | $1,102 |
| Clindamycin Phosphate | 11 | $396 |
| Pantoprazole Sodium | 31 | $336 |
| Niacin ErNiacin | 13 | $306 |
| Lactulose | 18 | $204 |
| Nystatin | 11 | $184 |
Paid to pharmacies, not to this prescriber.
Other pediatric gastroenterology in Miami
- Alisa Muniz CrimMiami$50K
- Erick HernandezMiami$12K
- Miguel SapsMiami$9K
- Jennifer GarciaMiami$6K
- Lina FelipezMiami$5K
- Richard ArboledaMiami$5K
- Luis Caicedo OquendoMiami$5K
- Jesse Reeves-GarciaMiami$5K
- Oscar Loret de MolaMiami$4K
- Laura IrastorzaMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.